menu search

Okyo pharma phase ii dry eye trial making encouraging progress

OKYO Pharma Ltd (NASDAQ:OKYO), the clinical-stage drug developer, has reported encouraging safety data for its ongoing phase II clinical trial of OK-1...

October 5, 2023, 7:58 am

Nzdcad short term forecast and technical analysis

Hi Traders! NZDCAD short term forecast and technical analysis is here. We do our analysis on the MetaTrader4 platform (MT4), some very interesting, us...

October 5, 2023, 7:40 am

Merck reports positive results in late-stage trial of keytruda as treatment for bladder cancer

Merck & Co. Inc. MRK, +0.39% said Thursday a late-stage trial of its cancer treatment Keytruda met its main goal of disease-free survival for ...

October 5, 2023, 7:26 am

Australian chevron strike threats place gas price under threat again

Workers at Chevron Corporation (NYSE:CVX)-operated liquified natural gas (LNG) terminals in Australia are reportedly mulling renewed strike action in ...

October 5, 2023, 7:13 am

Highpeak energy, inc. insiders continue to buy

InsiderTrades.com readers know that HighPeak Energy, Inc. NASDAQ: HPK insiders are buying in 2023. Purchasing has only been bullish for the last two y...

October 5, 2023, 7:11 am

Koru medical systems to present two abstracts at the immunoglobulin national society 2023 national conference

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focus...

October 5, 2023, 7:05 am

Oculis to present a late-breaking abstract at the 23rd euretina congress on positive phase 3 stage 1 diamond trial results for diabetic macular edema

ZUG, Switzerland, and BOSTON, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis” or the “Company”), a global biopharm...

October 5, 2023, 6:30 am

Gold price crash: safe to invest during festivals? here is what experts say

“In a familiar trend, Indians, during festivals, will go to jewellery stores, driving an anticipated ...

October 5, 2023, 6:14 am

Eur/usd forecast: analyzing german trade data amid recession fears

US labor market in focus; rising jobless claims could sway sentiment toward the hawkish Fed rate path a...

October 5, 2023, 5:31 am

Dax index: from ecb stance to german trade, navigating the financial landscape

Anticipation in the Dax Market: German trade data and ECB insights set the tone for investors. The post...

October 5, 2023, 5:20 am

Blackberry review – souped-up account of the rise and fall of ‘crackberry'

Hilarity and pathos intertwine in this likable comedy as the smartphone creators go loopy with wealth �...

October 5, 2023, 4:00 am

Ecb and riksbank speakers on thursday, 5 october 2023

Coming up today:0800 GMT / 0400 US Eastern time: ECB Governing Council member Peter Kazimir speaks at the National Bank of Slovakia's quarterly press ...

October 5, 2023, 2:45 am

Novartis to present new oncology data at esmo 2023 demonstrating practice-changing innovation in advanced prostate and early breast cancer

Basel, October 5, 2023 — Novartis will present new data from 29 Novartis and investigator-led abstracts at the European Society for Medical Oncology...

October 5, 2023, 1:15 am

Clean label ingredients market soars to us$ 169,024.9 million in 2033, bolstered by supplements and nutraceuticals | future market insights, inc.

Rising food allergy concerns drive growth in the clean-label ingredients market, influencing healthier, allergen-free product choices. NEWARK, Del, Oc...

October 5, 2023, 12:30 am

Purecycle technologies, inc. (pct) investor alert: robbins llp reminds shareholders of class action allegations against purecycle technologies, inc.

SAN DIEGO, Oct. 04, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities ...

October 4, 2023, 10:36 pm

Verastem: signs of life for a beaten-down equity

Verastem is a biotechnology company focused on developing novel agents for solid tumors, with its main candidate being avutometinib. Avutometinib is b...

October 4, 2023, 9:00 pm

path to prosperity: 3 growth stocks that can turn $10,000 to $1 million

At the core of every investment, the quest for long-term prosperity remains a constant pursuit. In this dynamic world, three companies are emerging as...

October 4, 2023, 8:56 pm

Clorox says cyberattack will impact first-quarter net sales, earnings

Clorox revealed Wednesday how much it anticipates the cyberattack that the company recently experienced...

October 4, 2023, 8:20 pm

Alx oncology announces proposed public offering

SOUTH SAN FRANCISCO, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), ...

October 4, 2023, 8:10 pm

Walmart finds appetite-suppressing medications affect shopping behavior

Walmart has reportedly found that customers who buy appetite-suppressing medications like the diabetes drug Ozempic are buying less food. The retaile...

October 4, 2023, 7:08 pm


Search within

Pages Search Results: